Predictions for 2025: Artificial Intelligence in Modern Drug Development, Quantum Proof Encryption, and Health Data Monetization

Authors

  • Ingrid Vasiliu-Feltes MD, EMBA Founder & CEO, Institute for Science, Entrepreneurship and Investments, and Faculty, University of Miami, Florida, USA, and CEO, Softhread, Catonsville, Maryland, USA
  • Jennifer Hinkel, MSc, CHW, FRSA The Data Economics Company, Los Angeles, California, USA
  • Olga Kubassova, PhD Image Analysis Group, London, United Kingdom

DOI:

https://doi.org/10.30953/bhty.v7.361

Keywords:

Artificial Intelligence, cloud platforms , Data mesh, Health Data Monetization, identity management , lattice-based cryptography , Modern Drug Development , Quantum Proof Encryption , blockchain for healthcare

Abstract

We are witnessing an unprecedented convergence of scientific discoveries, technology innovations, exponential adoption of technology and remarkable population demographic shifts towards a digitally native society. The Noble Prizes in medicine, chemistry, physics awarded this year further validated the profound impact of technology on healthcare and life sciences. For 2025-designated by the United Nations as The Year of Quantum Technology, we can envision further technology-driven innovations in all domains, triggering the transition to a novel health ecosystem. The role of AI in modern drug development, the demand for quantum-proof encryption, and the opportunities of blockchain in health data monetization are all trends can be disruptive for pharma, healthcare and healthcare finance.

Downloads

Download data is not yet available.

References

Bookbinder, M. (2017, September 29). The intelligent trial: AI comes to clinical trials. [cited 2018 Apr 11]. Available from: http://www.clinicalinformaticsnews.com/2017/09/29/the-intelligent-trial-ai-comes-to-clinical-trials.aspx

Brynjolfsson, E, Mcafee, A. (2018, February 01). The business of artificial intelligence. [cited 2018 Apr 12]. Available from: https://hbr.org/cover-story/2017/07/the-business-of-artificial-intelligence

Ronanki, R, Davenport, TH. Artificial intelligence for the real world. Harvard Business Review. 2018;108–116.

Collins L, Costello RA. Glucagon-like peptide-1 receptor agonists. [Updated 2024 Feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [cited 2018 Apr 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551568/

Downloads

Published

2024-12-16

How to Cite

Vasiliu-Feltes MD, EMBA, I., Hinkel, MSc, CHW, FRSA, J., & Kubassova, PhD, O. (2024). Predictions for 2025: Artificial Intelligence in Modern Drug Development, Quantum Proof Encryption, and Health Data Monetization. Blockchain in Healthcare Today, 7(3). https://doi.org/10.30953/bhty.v7.361

Issue

Vol. 7 No. 3 (2024): Blockchain in Healthcare Today Platform Approaches Journal

Section

Editorial

License

Copyright (c) 2024 Ingrid Vasiliu-Feltes MD, EMBA, Jennifer Hinkel, MSc, CHW, FRSA, Olga Kubassova, PhD

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors retain copyright of their work, with first publication rights granted to Blockchain in Healthcare Today (BHTY). Read the full Copyright Statement.